Valuation (69%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 81.38 | N/A |
| PEG Ratio (TTM) | -1.64 | N/A |
| P/S Ratio (TTM) | 0.80 | N/A |
| P/B Ratio (TTM) | 2.00 | N/A |
| P/FCF Ratio (TTM) | 18.35 | N/A |
| Price to 5YR AVG Earnings Ratio | 18.95 | N/A |
| Price to 5YR AVG FCF Ratio | 11.01 | N/A |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.23% | N/A |
| ROE (TTM) | 2.51% | N/A |
| Net Profit Margin (TTM) | 0.98% | N/A |
| ROIC 5YR AVG | 12.28% | N/A |
Growth (38%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -149.61% | -0.38% | -6.38% |
| Revenue | 0.27% | 6.86% | 11.10% |
| Net Income | -149.26% | 0.28% | -7.27% |
| Cash Flow | 84.10% | 43.81% | 37.87% |
Health (67%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.42 | N/A |
| Quick Ratio (TTM) | 0.71 | N/A |
| D/E Ratio (TTM) | 0.09 | N/A |
| Interest Coverage (TTM) | 43.71 | N/A |
| Piotroski F-Score | 8 | N/A |
| Altman Z-Score | 3.06 | N/A |
| LTL to 5YR AVG FCF | 2.46 | N/A |
| Shares Outstanding Growth 5YR AVG | -1.32% | N/A |